Genesis Therapeutics: Tackling Drug Discovery through AI

Evan Feinberg, founder and CEO of Genesis Therapeutics, discusses how his work in the lab led to the creation of Genesis, which uses AI to tackle the problem of drug discovery. The company takes an interdisciplinary approach, combining the expertise of chemists, software engineers, and machine learning researchers to develop their internal platform called Nucleus. This platform allows chemists to access the latest ML models for predicting various properties, enhancing productivity and providing human feedback. Feinberg emphasizes the importance of unifying biotech with AI to fundamentally change the drug discovery process.